New job opportunity at Eli Lilly and Co.

1 messages 1 people Latest: Jan 10, 2019

New job opportunity at Eli Lilly and Co.

From: Brian A Willis Date: January 10, 2019 job
Dear NMUsers community, Lilly is looking for a talented individual who can help us expand our QSP modeling capabilities. The scientists in the department of PK/PD & Pharmacometrics at Lilly are the leaders in research and development throughout the value chain from early Discovery to clinical and post-drug approval with the goal of identifying and developing the right drug at the right dose for the right patient and living the model-informed paradigm of drug research and development. Our organization is looking for a dynamic scientist who will be responsible for: * Implementing Pharmacometrics and Quantitative System Pharmacology modeling and simulation techniques to address key questions and influence portfolio decisions, including, but not limited to the application of drug-disease models, literature models, quantitative risk/benefit decision tools, quantitative systems pharmacology models and trial-design optimization analytics. * Contributing to the development of novel QSP platform(s) for key disease states and improving existing QSP platforms. * Anticipating and recognizing the issues affecting drug discovery/development and finding effective solutions by partnership and collaboration with cross-functional teams to enable decision-making. * Providing scientific expertise in multi-disciplinary project teams to support the selection of the right target, molecule, dose, patient population and development strategies. * Actively contribute to teams by engaging with fellow scientists within the group and in other disciplines as well as interact, teach and collaborate with scientists in academia. * Representing the group to increase visibility externally, through key publications, active leadership in key scientific organizations, industry trade groups or consortia. In summary, in this exciting scientific and technical role, the qualified candidate will have opportunities to apply MIDD principles to drug research and development strategies, help set direction for the organization, and drive successful implementation of the strategies to produce results. The minimum qualifications for the job are * a master's or advanced degree in a relevant scientific discipline such as biological/pharmaceutical sciences, bioengineering or related field with 8 years of relevant experience or * a PhD and/or MD in a relevant scientific field such as biological/pharmaceutical sciences, bioengineering or related field. The preferred candidate will have experience in quantitative pharmacology modeling, an understanding of systems pharmacology principles, will be proficient in quantitative modeling and simulation software (such as SimBiology, NONMEM, MATLAB, R/S-plus etc.), will have excellent communication skills, and works effectively in team environments. This position can be located either in Indianapolis, US, or Erl Wood, UK. If you are interested in this exciting opportunity, please apply at: https://careers.lilly.com/job/indianapolis/research-scientist-quantitative-systems-pharmacology-pharmacometrician/410/10474706 Lilly is an EEO/Affirmative Action Employer and does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status. We look forward to hearing from you! Best regards, Brian Brian A. Willis, PhD Group Leader, Pharmacometrics Research Advisor, PK/PD and Pharmacometrics Eli Lilly and Company Lilly Corporate Center, Indianapolis IN 46285 USA 317.651.1308 (office) | 317.220.9191 (mobile) [email protected] | www.lilly.com CONFIDENTIALITY NOTICE: This e-mail message (including all attachments) is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure, copying or distribution is strictly prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message.